The use of additives to modulate the release of a sparingly water soluble drug entrapped in PLA50 microparticles: In vivo investigation

Journal of Microencapsulation

Volumn 17, Issue 1, 2000, Pages 95-110

  Mallard, C ^a   Coudane, J ^a   Rault, I ^b   Vert, M ^a  

^a CNRS   (France)

^b Service Galénique   (France)

Author keywords

Controlled drug delivery; In vivo release; Microparticles; Pharmacokinetics; Poly (DL lactic acid); Sparingly soluble drugs

Indexed keywords

1 (2 (4 FLUOROBENZOYL)AMINOETHYL) 4 (7 METHOXYNAPHTHYL)PIPERAZINE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DRUG; MACROGOL; MICROSPHERE; POLOXAMER; POLYLACTIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; FLUOROMETRY; MALE; MICROENCAPSULATION; NONHUMAN; RAT; SUSTAINED DRUG RELEASE;

EID: 0033985416     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.1080/026520400288580     Document Type: Article

References (15)

1. DESLANDES, A., 1995, Développement d'une méthode de calcul de profils d'absorption par déconvolution. Application à l'étude de l'absorption d'antibiotiques. Thèse de doctorat, Université de Paris-Sud, France.
2. DESLANDES, A., WESTPHAL, J. F., TROUVIN, J. H., and FARINOTTI, R., 1992, Adaptive computer program for determination of absorption profiles by numerical deconvolution: Application to amoxicillin absorption. Journal of Pharmaceutical Science, 81, 802-807.
3. FORD, J. L., 1986, The current status of solid dispersions. Pharmaceutica Acta Helvetica, 61, 69.
4. JUNI, K., OGATA, J., MATSUI, M., KUBOTA, M., and NAKANO, M., 1985, Modification of the release rate of aclarubicin from polylactic acid microspheres by using additives. Chemical Pharmaceutical Bulletin, 33, 1734-1738.
5. LALLA, J. K., and SAPNA, K., 1993, Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route. Journal of Microencapsulation, 10, 449-460.
6. LANGERBUCHER, F., and MÖLLER, F., 1983, Correlation of in vitro release with in vivo response kinetics. Part I: Mathematical treatment of time functions, Pharmaceutics and Industry, 45, 623-630.
7. LAVIELLE, G., LAUBIE, M., and COLPAERT, F., 1991, 1-Naphthylpiperazine derivatives, process for their preparation and pharmaceutical compositions containing them. Eur. Pat. Appl. EP 434, 561 (Cl. C07D295/12).
8. LEBLANC, P. P., AIACHE, J. M., BESNER, J. G., BURI, P., and LESNE, M., 1997, Traité de biopharmacie et pharmacocinétique (Canada: Les presses de l'Université de Montréal).
9. MALLARD, C., COUDANE, J., RAULT, I., and VERT, M., 1999a, PEG as an excipient to adjust the delivery of a sparingly water soluble anxiolitic drug from PLA microparticles, Journal of Microencapsulation, to be published
10. MALLARD, C., COUDANE, J., RAULT, I., and VERT, M., 1999b, The use of additives to modulate the release of a sparingly water soluble drug entrapped in PLA50 microparticles. Journal of Microencapsulation, to be published.
11. POIRIER-LITTRE, M. F., 1989, Système sérotoninergique et dépression. Conférence de l'Institut Pasteur, 3, Masson Ed., Paris, France.
12. POWERS, J. D., 1993, Statistical considerations in pharmacokinetics study design, Clinical Pharmacokinetics, 24, 380-387.
13. SANSDRAP, P., and MOËS, A. J., 1998, Influence of additives on the release profiles of nifedipine from poly(D,L-lactide-co-glycolide) microspheres. Journal of Microencapsulation, 15, 545-553.
14. SCHWACH, G., COUDANE J., ENGEL, R., and VERT, M., 1994, Stannous octoate versus zinc initiated polymerization of racemic lactide. Effects on configurational structures. Polymer Bulletin, 32, 617-623.
15. VENG-PEDERSEN, P., 1988, Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations. Journal of Pharmacokinetics and Biopharmaceutics, 16, 413-472.